Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Does warfarin therapy influence the risk of bladder cancer?

Blumentals WA, Foulis PR, Schwartz SW, Mason TJ.

Thromb Haemost. 2004 Apr;91(4):801-5.

PMID:
15045143
2.

Analgesic therapy and the prevention of bladder cancer.

Blumentals WA, Foulis PR, Schwartz SW, Mason TJ.

Urol Oncol. 2004 Jan-Feb;22(1):11-5.

PMID:
14969797
3.

Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.

Agarwal S, Bennett D, Smith DJ.

Am J Cardiovasc Drugs. 2010;10(1):37-48. doi: 10.2165/11318870-000000000-00000.

PMID:
20104933
4.

Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender.

Samanic C, Kogevinas M, Dosemeci M, Malats N, Real FX, Garcia-Closas M, Serra C, Carrato A, García-Closas R, Sala M, Lloreta J, Tardón A, Rothman N, Silverman DT.

Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1348-54. Erratum in: Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1568.

5.

A case-control study of smoking and bladder cancer risk: emergent patterns over time.

Baris D, Karagas MR, Verrill C, Johnson A, Andrew AS, Marsit CJ, Schwenn M, Colt JS, Cherala S, Samanic C, Waddell R, Cantor KP, Schned A, Rothman N, Lubin J, Fraumeni JF Jr, Hoover RN, Kelsey KT, Silverman DT.

J Natl Cancer Inst. 2009 Nov 18;101(22):1553-61. doi: 10.1093/jnci/djp361. Epub 2009 Nov 16.

6.

Case-control analysis of dietary folate and risk of bladder cancer.

Schabath MB, Spitz MR, Lerner SP, Pillow PC, Hernandez LM, Delclos GL, Grossman HB, Wu X.

Nutr Cancer. 2005;53(2):144-51.

PMID:
16573375
7.

Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.

Wang YH, Yeh SD, Wu MM, Liu CT, Shen CH, Shen KH, Pu YS, Hsu LI, Chiou HY, Chen CJ.

J Hazard Mater. 2013 Nov 15;262:1139-46. doi: 10.1016/j.jhazmat.2012.08.056. Epub 2012 Sep 7.

PMID:
23009795
8.

Urinary bladder cancer risk factors in men: a Spanish case-control study.

Baena AV, Allam MF, Del Castillo AS, Díaz-Molina C, Requena Tapia MJ, Abdel-Rahman AG, Navajas RF.

Eur J Cancer Prev. 2006 Dec;15(6):498-503.

PMID:
17106329
9.

Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study.

Tagalakis V, Tamim H, Blostein M, Collet JP, Hanley JA, Kahn SR.

Lancet Oncol. 2007 May;8(5):395-402.

PMID:
17466896
10.

GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.

Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B, Suvakov S, Savic-Radojevic A, Pljesa-Ercegovac M, Tulic C, Coric V, Simic T.

Urol Oncol. 2013 Oct;31(7):1184-92. doi: 10.1016/j.urolonc.2011.08.005.

PMID:
24075358
11.

Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events.

Sun AJ, Djaladat H, Schuckman A, Miranda G, Cai J, Daneshmand S.

J Urol. 2015 Feb;193(2):565-9. doi: 10.1016/j.juro.2014.08.085. Epub 2014 Aug 20.

PMID:
25150642
12.

Gender- and smoking-related bladder cancer risk.

Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC.

J Natl Cancer Inst. 2001 Apr 4;93(7):538-45.

PMID:
11287448
13.

Risk of hemorrhage and treatment costs associated with warfarin drug interactions in patients with atrial fibrillation.

Suh DC, Nelson WW, Choi JC, Choi I.

Clin Ther. 2012 Jul;34(7):1569-82. doi: 10.1016/j.clinthera.2012.05.008. Epub 2012 Jun 19.

PMID:
22717419
14.

Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries.

Sala M, Cordier S, Chang-Claude J, Donato F, Escolar-Pujolar A, Fernandez F, González CA, Greiser E, Jöckel KH, Lynge E, Mannetje A, Pohlabeln H, Porru S, Serra C, Tzonou A, Vineis P, Wahrendorf J, Boffetta P, Kogevina M.

Cancer Causes Control. 2000 Dec;11(10):925-31.

PMID:
11142527
15.

Pioglitazone use and the risk of bladder cancer.

Kuo HW, Tiao MM, Ho SC, Yang CY.

Kaohsiung J Med Sci. 2014 Feb;30(2):94-7. doi: 10.1016/j.kjms.2013.09.011. Epub 2013 Oct 29.

16.

Use of warfarin therapy among residents who developed venous thromboembolism in the nursing home.

Reardon G, Pandya N, Nutescu EA, Lamori J, Damaraju CV, Schein J, Bookhart BK.

Am J Geriatr Pharmacother. 2012 Dec;10(6):361-72. doi: 10.1016/j.amjopharm.2012.11.003.

PMID:
23217529
17.

Major bleeding risk associated with warfarin and co-medications in the elderly population.

Vitry AI, Roughead EE, Ramsay EN, Preiss AK, Ryan P, Gilbert AL, Caughey GE, Shakib S, Esterman A, Zhang Y, McDermott RA.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1057-63.

PMID:
22039594
18.
19.

Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa.

Chiu BC, Lynch CF, Cerhan JR, Cantor KP.

Ann Epidemiol. 2001 Jan;11(1):28-37.

PMID:
11164117
20.

Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.

Gan J, Skipper PL, Gago-Dominguez M, Arakawa K, Ross RK, Yu MC, Tannenbaum SR.

J Natl Cancer Inst. 2004 Oct 6;96(19):1425-31.

PMID:
15467031

Supplemental Content

Support Center